Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
10/03/2002 | CA2442019A1 Sex-specific selection of sperm from transgenic animals |
10/03/2002 | CA2442010A1 New elongase gene and production of.delta. 9-polyunsaturated fatty acids |
10/03/2002 | CA2441721A1 Human potassium channel |
10/03/2002 | CA2441708A1 Mch1r deficient mice |
10/03/2002 | CA2441580A1 Coagulation factor vii derivatives |
10/03/2002 | CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
10/03/2002 | CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
10/03/2002 | CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
10/03/2002 | CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
10/03/2002 | CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same |
10/02/2002 | EP1245145A1 Device for vegetal production and small animal breeding |
10/02/2002 | EP1244916A1 INHIBITION OF $g(b)ARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA |
10/02/2002 | EP1244796A2 Transduction of recombinases for inducible gene targeting |
10/02/2002 | EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
10/02/2002 | EP1244461A2 INHIBITION OF GSK-3$g(b) |
10/02/2002 | EP1244433A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
10/02/2002 | EP1244352A2 Oocyte vitrification technique |
10/02/2002 | EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal |
10/02/2002 | CN2513357Y Insect culturing device for mass-producing oriental army worm and beet armyworm |
09/26/2002 | WO2002075304A1 Method of examining allergic disease |
09/26/2002 | WO2002075302A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
09/26/2002 | WO2002074965A2 Characterization of the i-spoml endonuclease from fission yeast |
09/26/2002 | WO2002074948A2 Animal tissue with carbohydrate antigens compatible for human transplantation |
09/26/2002 | WO2002074935A2 Use of telomerase reverse transcriptase to create homozygous knockout animals |
09/26/2002 | WO2002074345A2 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules |
09/26/2002 | WO2002074078A2 Method for embryo after impregnation of the recipient female |
09/26/2002 | WO2002074077A1 Skin disease model mice, feed for constructing the same and method of evaluating test substance with the use of the mice |
09/26/2002 | WO2002074072A2 Method for determining the therapeutic efficacy of a medicament against parkinson's disease and/or parkinson syndrome using an fri/fri mouse as a model |
09/26/2002 | WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus |
09/26/2002 | WO2002038752A3 Use of a helminth for the in vivo delivery of a medicament |
09/26/2002 | WO2002026954A3 Truncated phosphodiesterase-7 polypeptides |
09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
09/26/2002 | WO2001095711A3 Transgenic mice containing nuclear hormone receptor gene disruptions |
09/26/2002 | WO2001088109A8 Model for neurodegenerative disease |
09/26/2002 | US20020138874 Elongase genes and uses thereof |
09/26/2002 | US20020138865 In vitro transfection, storage and transfer of male germ cells for generation of transgenic species & genetic therapies |
09/26/2002 | US20020138862 Mice show an increased insulin sensitivity, and resistance to weight gain compared to wild-type mice on same diet; screening for enzyme inhibitors; antiobesity, antidiabetic agents |
09/26/2002 | US20020138861 Mice models of human prostate cancer progression |
09/26/2002 | US20020138860 Novel uses of mammalian CCR6 receptors and related reagents |
09/26/2002 | US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
09/26/2002 | US20020138856 Rat selectively bred to be more depressed, as defined by a forced swim test immobility score; screening for antidepressants, genes responsible for depression |
09/26/2002 | US20020138855 Non-invasive evaluation of physiological response in a mammal |
09/26/2002 | US20020137700 Nucleic acids; genetic engineering |
09/26/2002 | US20020137211 Method for establishing an expression system of spider dragline silk gene in bombyx mori |
09/26/2002 | US20020137209 Nongenotropic effect occurs due to a ligand-induced activation of the ligand binding domain and genotropic effect occurs due to a ligand-induced activation of the DNA-binding domain of a steroid receptor |
09/26/2002 | US20020137184 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and use thereof |
09/26/2002 | US20020137137 Genetic engineering; polypeptides |
09/26/2002 | US20020137115 Cgmp- visualizing probe and a method of detecting and quantifying of cgmp by using the same |
09/26/2002 | US20020137100 Method for determining the fertility of mammals, especially of humans |
09/26/2002 | US20020137049 Pablo, a polypeptide that interacts with Bcl-xL, and uses related thereto |
09/26/2002 | US20020137041 Using fish models; cancer therapy |
09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
09/26/2002 | US20020136754 Recombinant bacterial phytases and uses thereof |
09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
09/26/2002 | CA2441289A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
09/26/2002 | CA2440966A1 Characterization of the i-spomi endonuclease from fission yeast |
09/26/2002 | CA2435857A1 Methods for embryo recipient management |
09/25/2002 | EP1243646A2 Transgenic Drosophila with human APC gene for pharmacological screenings |
09/25/2002 | EP1242629A2 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
09/25/2002 | EP1242607A1 Transgenic insect |
09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
09/25/2002 | EP1241936A1 A method to produce cloned embryos and adults from cultured cells |
09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
09/25/2002 | EP1241934A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
09/25/2002 | EP1241933A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
09/25/2002 | EP1241932A1 Animal models for cardiac disease |
09/25/2002 | EP1241931A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine. |
09/25/2002 | EP1049800A4 Asthma related genes |
09/25/2002 | CN2512794Y Plastic flat wire braided silkworm net |
09/25/2002 | CN1371416A Human CTLA-4 antibodies and their uses |
09/25/2002 | CN1371390A Human G-protein coupled receptor |
09/25/2002 | CN1371243A Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
09/25/2002 | CN1370404A Silkworm egg cold storing and hatching and silkworm collecting method |
09/25/2002 | CN1370403A Stereo scorpion culture method in plastic basin |
09/24/2002 | US6455757 Transgenic mice expressing human APP and TGF-β demonstrate cerebrovascular amyloid deposits |
09/24/2002 | US6455756 Immune defective rodent for use as animal model in evaluating blood diosrders |
09/24/2002 | US6455755 Leukotriene B4 receptor transgenic mice |
09/24/2002 | US6455754 Screening for modulators of neuronal receptor binding activity; obtain animal model, incubate with modulator, monitor adjustments in neuronal activity |
09/24/2002 | US6455685 Detecting modulators of immune response; obtain nucleotide sequences, incubate with modulator, remove unbound modulator, detect bound complexes |
09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
09/24/2002 | US6455291 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
09/24/2002 | US6455246 Human xenografts for microbicide testing and anatomical modeling |
09/24/2002 | US6454756 Injector of sperm for artificial insemination or fertilized ovum for transplantation of domestic animal and method of operating thereof |
09/19/2002 | WO2002073188A1 Method for generating replacement cells and/or tissues |
09/19/2002 | WO2002073187A1 Method for generating replacement cells and/or tissues |
09/19/2002 | WO2002072844A1 Novel expression vectors |
09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
09/19/2002 | WO2002072788A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
09/19/2002 | WO2002072551A2 A non-traumatic model for neurogenic pain |
09/19/2002 | WO2002072028A2 Compositions and methods for modifying the content of polyunsaturated fatty acids in mammalian cells |
09/19/2002 | WO2002072024A2 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto |
09/19/2002 | WO2002072023A2 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
09/19/2002 | WO2002072017A2 Method of drug target validation |
09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
09/19/2002 | WO2002029002A3 Method for generating cloned animals using chromosome shuffling |
09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
09/19/2002 | WO2002017949A9 Novel functions for dp214 |
09/19/2002 | WO2002002765A3 Chimeric promoters for controlling expression in smooth muscle cells |